Cardioprotection Resulting from Glucagon-Like Peptide-1 Administration Involves Shifting Metabolic Substrate Utilization to Increase Energy Efficiency in the Rat Heart-Reference-Cited by-同舟云学术

Cardioprotection Resulting from Glucagon-Like Peptide-1 Administration Involves Shifting Metabolic Substrate Utilization to Increase Energy Efficiency in the Rat Heart

Published:2015-06-22 Issue:6 Volume:10 Page:e0130894
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Aravindhan Karpagam,Bao Weike,Harpel Mark R.,Willette Robert N.,Lepore John J.,Jucker Beat M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury;AK Bose;Diabetes,2005

2. GLP-1 therapy beyond glucose control;DJ Hausenloy;Circ Heart Fail,2008

3. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion;LA Nikolaidis;Circulation,2004

4. Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure;GG Sokos;J. Card. Fail.,2006

5. Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting;GG Sokos;Am. J. Cardiol.,2007

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery Disease;2024-08-16

2. The benefits of oral glucose-lowering agents: GLP-1 receptor agonists, DPP-4 and SGLT-2 inhibitors on myocardial ischaemia/reperfusion injury;European Journal of Pharmacology;2024-08

3. The impact of glucagon-like peptide-1 receptor agonists in the patients undergoing anesthesia or sedation: systematic review and meta-analysis;Perioperative Medicine;2024-07-22

4. Underlying mechanisms and cardioprotective effects of SGLT2i and GLP-1Ra: insights from cardiovascular magnetic resonance;Cardiovascular Diabetology;2024-03-11

5. Beyond Weight Loss: the Emerging Role of Incretin-Based Treatments in Cardiometabolic HFpEF;Current Opinion in Cardiology;2024-01-31